RESUMEN
Precursor lesions of spontaneous nephroblastoma (NB) in rats are here characterized for the first time, with a description of the progression of the tumor in prenatal, postnatal, and adult Sprague-Dawley rats (Upj:TUC[SD]spf.nb), which are genetically predisposed to the tumor. NB in the rat starts as a focal or multifocal interstitial accumulation of intensely basophilic immature (blastema) cells, invariably located in the deep renal cortex. Precursor lesions of NB (designated intralobar nephroblastematosis) and the early tumor do not overtly disrupt the overall structural organization and integrity of the kidney. However, with increasing size and neoplastic transformation, these lesions trap, compress, and displace/replace the existing renal tubules. Nephroblastematous foci occurred in one or both kidneys in tumor-bearing or non-tumor-bearing kidneys and in young and old rats. Like the precursor lesions, the early tumors in rats as young as 6 weeks of age were located in the inner cortex. Well-developed NB was comprised of blastema cells arranged in dense sheets or in ductular structures surrounded by mantles of blastema cells supported by varying amounts of fibromatous stroma. The stroma in one rat was hemangiosarcomatous (triphasic Wilms' tumor). Tumor cells were slightly pleomorphic and had varying amounts of granular cytoplasm with sparse organelles and showed junctional complexes and basal laminae whose frequency apparently depended upon whether the blastema cell tended to differentiate to epithelial or mesenchymal cells. NB in the rat was morphologically similar to immature pre- and postnatal kidneys, regardless of whether it occurred in young or old rats. The deep cortical location and interstitial infiltrative characteristics of precursor lesions of NB in the rat were analogous to intralobar nephrogenic rests, a variant of the precursor to Wilms' tumor in children.
Asunto(s)
Neoplasias Renales/patología , Lesiones Precancerosas/patología , Tumor de Wilms/patología , Animales , Animales Recién Nacidos , Transformación Celular Neoplásica/patología , Cesárea , Modelos Animales de Enfermedad , Femenino , Feto , Predisposición Genética a la Enfermedad , Riñón/patología , Neoplasias Renales/genética , Neoplasias Renales/ultraestructura , Masculino , Microscopía Electrónica , Compuestos Organometálicos/química , Reacción del Ácido Peryódico de Schiff , Lesiones Precancerosas/genética , Lesiones Precancerosas/ultraestructura , Embarazo , Ratas , Ratas Sprague-Dawley , Tumor de Wilms/genética , Tumor de Wilms/ultraestructuraRESUMEN
PURPOSE: To compare the venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats after intravenous administration of a submicron lipid emulsion with that of an aqueous solution. METHODS: Venous irritation was determined by microscopic evaluation of injury to the lateral tail veins of rats. Pharmacokinetic parameters were determined by following plasma concentrations of drug. Tissue distribution of [14C]-tirilazad was determined by quantitative whole body autoradiography. RESULTS: Single dose injections of tirilazad as an emulsion at doses ranging from 1.52 mg to 13.5 mg were non-irritating whereas the solution was irritating at a dose of 1.3 mg. The pharmacokinetic parameters were not statistically different between the emulsion and the solution (p > 0.2) at doses of 6 mg/kg/day and 20 mg/kg/day. However, at 65 mg/kg/day dose, a higher AUC(0,6) (4-fold) and lower V(ss), (18-fold) and CL(5-fold) were observed for the lipid emulsion as compared to the solution (p < 0.05). Tissue distribution showed higher initial concentrations (two fold or more) in most tissues for the solution. These values, however, equilibrated by 4 h and AUC(0,4) differences were less than two fold in most tissues. CONCLUSIONS: Formulating tirilazad in the lipid emulsion significantly reduces the venous irritation without changing the pharmacokinetics and tissue distribution at low doses.
Asunto(s)
Depuradores de Radicales Libres/farmacocinética , Pregnatrienos/farmacocinética , Venas/efectos de los fármacos , Animales , Área Bajo la Curva , Química Farmacéutica , Emulsiones/efectos adversos , Emulsiones/farmacocinética , Femenino , Depuradores de Radicales Libres/efectos adversos , Inyecciones Intravenosas , Lípidos/efectos adversos , Lípidos/farmacocinética , Masculino , Pregnatrienos/efectos adversos , Ratas , Ratas Sprague-Dawley , Distribución TisularRESUMEN
The threshold hemodynamic changes associated with the cardiovascular (CV) toxicity of minoxidil (MNX) in the dog, characterized by subendocardial necrosis, right atrial hemorrhagic lesions, and coronary vascular medial hemorrhage and necrosis, have not been defined. To determine the relationship between serum concentration, hemodynamic effects [heart rate (HR) and mean arterial pressure (MAP)] and CV toxicity, groups of female Beagle dogs were treated with a continuous iv infusion of dextrose (control) or 0.05, 0.14, 0.43, 1.44, or 4.32 mg/kg/day of MNX for 3 days. Serum concentration of free MNX increased in a dose-related manner and reached steady state within 4 hr after the initiation of infusion. There was a time-dependent, apparently dose-related increase in HR at all doses. MAP was decreased at > or = 0.14 mg/kg/day in a time- and dose-related manner. The doses or steady-state serum concentrations of MNX that showed no significant hemodynamic effects and CV toxicity were approximately 0.05 mg/kg or 3.0 +/- 0.6 ng/ml and 0.14 mg/kg or 7.3 +/- 2.0 ng/ ml, respectively. CV toxicity occurred at a serum concentration of 16.6 +/- 1.9 ng/ml where HR was increased by 65 +/- 11 beats/min and MAP was decreased by 34 +/- 2 mm Hg. A serum concentration of 7.3 +/- 2 ng/ml of MNX that increased HR by 47 +/- 14 beats/min and decreased MAP by 17 +/- 8 mm Hg was not associated with CV toxicity. This study suggests that the threshold hemodynamic effects associated with the CV toxicity of MNX in the dog are a function of an increase in HR by at least 55 beats/min and a decrease in MAP by at least 30 mm Hg. In conclusion, the safety margin of drugs like MNX, where the mechanisms of toxicity are known to be related to their pharmacologic effects, should be based on the ratio of the pharmacokinetically and metabolically adjusted dose/serum concentration of the drug that evokes comparable pharmacologic effects in the animal model and humans rather than on the ratio of the nontoxic dose/serum concentration in animals to the efficacious dose in humans.
Asunto(s)
Enfermedad Coronaria/patología , Minoxidil/efectos adversos , Minoxidil/sangre , Animales , Presión Sanguínea/efectos de los fármacos , Enfermedad Coronaria/inducido químicamente , Perros , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Minoxidil/farmacocinéticaRESUMEN
There has been no satisfactory animal model for hereditary nephroblastoma (NB; Wilms' tumor), the most common malignant renal tumor in children. A rat subline with a high incidence of NB, designated Upj:TUC(SD)spf.nb, was established from tumor-bearing Upjohn Sprague Dawley (Upj:TUC[SD]spf) stock rats by inbreeding. Incidence of NB was increased from 2.2% (1/46) to 33.0% (4/12) in males and from 10.0% (5/50) to 58.3% (7/12) in females through four successive generations of sister-to-brother mating. The overall incidence of NB-6.5% (14/214) in males and 21.6% (49/227) in females-was over 150-fold higher than the incidence of the tumor in other strains of rats. Of the 63 tumors, 47 (75%) developed at 4 to 12 months of age, and 32 (51%) developed at 7 to 9 months of age. Twelve of the tumors (19%) were bilateral, and in four rats (6.3%) the tumor was triphasic Wilms' tumor. Five of the tumors invaded the adjoining abdominal organs; none metastasized to distant organs. The tumor was consistently transplanted to syngeneic rats through 10 successive passages. The transplanted tumor, as the primary tumor, was composed of blastemoepithelial cells. The Upj:TUC(SD) spf.nb rat with a high incidence of NB, established at the Upjohn Company and donated to the Cleveland Clinic, may be an appropriate animal model for NB (Wilms' tumor) in children.
Asunto(s)
Neoplasias Renales/veterinaria , Ratas Sprague-Dawley/genética , Enfermedades de los Roedores/genética , Tumor de Wilms/veterinaria , Animales , Modelos Animales de Enfermedad , Femenino , Incidencia , Riñón/patología , Neoplasias Renales/epidemiología , Neoplasias Renales/patología , Masculino , Trasplante de Neoplasias , Tamaño de los Órganos , Linaje , Ratas , Tumor de Wilms/patologíaRESUMEN
Minoxidil (MNX), like several other vasoactive drugs, causes cardiovascular toxicity in dogs by undetermined mechanisms. We studied the mechanism of cardiovascular toxicity of MNX [an adenosine triphosphate (ATP)-sensitive potassium channel opener] by blocking its pharmacologic effects with glyburide (an ATP-sensitive potassium channel blocker) in groups of 5 female beagle dogs treated orally for 2 days with 1.0 mg/kg/day of MNX alone or with glyburide given in 5 or 6 divided doses of 300 mg/kg at 2 hr before and after each dose of MNX and at 3-6-hr intervals thereafter. A third group of 5 dogs received glyburide alone in the same dosing regimen as in the combination group. Mean arterial pressure (MAP), heart rate (HR), the pharmacokinetics of MNX, and gross and microscopic changes in the heart were evaluated. Glyburide did not influence the pharmacokinetics of MNX but prevented or markedly attenuated the MNX-induced cardiovascular lesions (right atrial hemorrhagic lesions, subendocardial necrosis, or coronary arteritis) occurred in dogs whose MNX-induced hemodynamic effects were effectively blocked by glyburide. In conclusion, the cardiovascular toxicity of MNX in dogs is not caused by a direct toxic effect of MNX on the heart but apparently is related to the exaggerated pharmacologic/profound hemodynamic effects it elicits in the dog.
Asunto(s)
Corazón/efectos de los fármacos , Minoxidil/toxicidad , Vasodilatadores/toxicidad , Animales , Análisis Químico de la Sangre , Presión Sanguínea/efectos de los fármacos , Perros , Femenino , Gliburida/farmacología , Frecuencia Cardíaca/efectos de los fármacos , Ventrículos Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/patología , Minoxidil/antagonistas & inhibidores , Minoxidil/farmacocinética , Miocardio/patología , Canales de Potasio/efectos de los fármacos , Relación Estructura-Actividad , Vasodilatadores/antagonistas & inhibidores , Vasodilatadores/farmacocinéticaRESUMEN
This report discusses a unique drug-induced hepatotoxicity in cynomolgus monkeys treated orally with a novel potassium sparing experimental diuretic, [2,6-bis(4-chlorophenyl)-4-pyridinecarboxylic acid]. Groups of 6 adult male and female monkeys were treated orally with vehicle diluent, modified vehicle #122 or a suspension of the drug at 5.0, 12.5, or 32.0 mg/kg/day for 2 weeks. Another group of 5 monkeys were treated orally with 25.0 mg/kg/day of the drug for 2 weeks. Disposition of the drugs was evaluated in 2 monkeys in the later group that received 27.4 mg/kg of radiolabelled drug on the 1st and last day of dosing. Hepatic toxicity was characterized biochemically, light and electron microscopically, histochemically, immunocytochemically, and toxico-kinetically. Conjugated serum bilirubin, alanine transaminase, and aspartate transaminase levels were increased in monkeys treated with over 12.5 mg/kg/day of the diuretic. The periacinar hepatic plates of monkeys treated with 25.0 or 32.0 mg/kg/day were distorted by accumulation of PAS and oil red-O positive multinucleated Kupffer cells. The cytosol of these cells was expanded by phagolysosomes containing granular materials of varying electron densities. Granular electron dense materials were also in endothelial cells and bile canaliculi. Fatty change, cholestasis, and rare piecemeal hepatic necrosis were minimal. The drug was primarily excreted through urine. Plasma concentration and half life of the drug were increased with multiple dosing. The highest concentration of unexcreted parent drug was in the liver. Drug-induced noninflammatory hepatic microgranulomatosis, apparently caused by sequestered drug-lipid/mucopolysaccharide complex in the phagocytic cells of the liver, can occur in any species, including humans, if orally administered xenobiotics are presented to the liver in particulate form.
Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Diuréticos/toxicidad , Granuloma/patología , Ácidos Isonicotínicos/toxicidad , Animales , Recuento de Células Sanguíneas , Peso Corporal/efectos de los fármacos , Diuréticos/farmacocinética , Heces/química , Femenino , Granuloma/inducido químicamente , Ácidos Isonicotínicos/farmacocinética , Macaca fascicularis , Masculino , Microscopía Electrónica , Manejo de Especímenes , Distribución TisularRESUMEN
Minoxidil and other potent vasodilators cause coronary arterial injury, right atrial hemorrhagic lesions, and subendocardial necrosis in dogs. This paper discusses the pathogenesis of coronary arterial and right atrial lesions associated with minoxidil in the dog. Acute coronary vascular injury characterized by segmental medial hemorrhage and necrosis and perivascular inflammation occurred only during the first few days of treatment, after which tolerance to further acute injury developed. At 30 d or more of treatment, coronary vascular injury was characterized by perivascular fibrosis rarely attended by medial distortion or hyperplasia and subintimal thickening, changes consistent with responses to previous injury. Right atrial hemorrhagic lesions, unlike coronary vascular injury, often became progressively more extensive with continued treatment. At 3 d, atrial hemorrhage and inflammation were confined to the subepicardium of the right atrium, evidently around affected subepicardial branches of the right coronary artery. At 30 d, fibrovascular proliferative right atrial lesions (granulation tissue with evidence of continual hemorrhage) extended from the epicardium to the myocardium, with eventual replacement of the atrial wall by mature connective tissue at 1 yr of treatment. Minoxidil-induced cardiovascular lesions were not prevented by treatment with a beta-blocker (propranolol), or an alpha-blocker (dibenzylene), or by sympathetic neural activity suppression (surgical sympathectomy or constant carotid sinus nerve stimulation), suggesting that the sympathetic response to the pharmacologic activity of minoxidil was not responsible for the induction of the cardiovascular lesions. Minoxidil-related vascular lesions were confined to the most pharmacologically responsive segment of the arterial system, the coronary arteries, suggesting that medial injury may have been associated with tensile changes in the arterial wall.
Asunto(s)
Enfermedades Cardiovasculares/fisiopatología , Minoxidil/toxicidad , Antagonistas Adrenérgicos beta/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Enfermedades Cardiovasculares/inducido químicamente , Enfermedades Cardiovasculares/patología , Seno Carotídeo/fisiología , Circulación Coronaria/efectos de los fármacos , Perros , Estimulación Eléctrica , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Hemorragia/inducido químicamente , Hemorragia/patología , Masculino , Necrosis/inducido químicamente , Necrosis/patología , Simpatectomía , Sistema Nervioso Simpático/fisiopatologíaRESUMEN
Groups of 25 male Sprague-Dawley rats were treated by gastric intubation with either vehicle control (modified methylcellulose) or a suspension of losulazine at 4, 8, 16, or 32 mg/kg/day for 1 yr. Ten rats/group were killed after 6 months of treatment. Reversibility of drug-induced changes was evaluated in 8 rats/group treated for 6 months and held without treatment for 5 months. Daily clinical signs and weekly body weight changes were monitored. Seminal vesicle/coagulating glands were weighed in rats treated for 6 months. Gross and microscopic evaluation of the accessory sex glands (ampullary glands, prostate, seminal vesicles and coagulating glands) was conducted in all rats killed at 6 months, after the recovery period, and in rats that survived through the one-yr treatment period. Ptosis, somnolence, and fecal softening were detected in all groups treated with losulazine. There was a nonreversible body weight gain retardation in groups treated with 8 to 32 mg/kg/day of losulazine for 6 months or 1 yr. Absolute and relative weights of the seminal vesicle/coagulating glands of treated rats were not significantly different from those of control rats. The ventral prostate in a few rats in all treated groups had yellow to tan granular foci. Treatment, but not dose-related sperm granulomas or glandular impaction with inspissated secretion (formation of corpora amylacia) in the ampullary glands, enhanced cellular exudation into the acini of the ventral prostate, and impaction of the seminal vesicles with altered granular to globular secretion were found in rats treated with losulazine.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Antihipertensivos/toxicidad , Piperazinas/toxicidad , Próstata/efectos de los fármacos , Vesículas Seminales/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Glándulas Exocrinas/efectos de los fármacos , Glándulas Exocrinas/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Próstata/patología , Ratas , Ratas Endogámicas , Vesículas Seminales/patologíaRESUMEN
Cardiovascular changes associated with indwelling catheters were evaluated in 51 adult beagle dogs catheterized for 4 to 9 weeks. Pathologic changes consistent with traumatic injury were in the vena cava and endocardium of the right atrium of 88% of cannulated dogs. Lesions were characterized by surface denudation and diffuse intimal thickening due to myointimal hyperplasia and deposition of extracellular matrix. Affected intima was lined by hyperplastic, poorly differentiated endothelial cells and contained round to oval cells with characteristics of smooth muscle cells. After 9 weeks, thickened intima was vascularized and composed of spindle-shaped cells and fibrillar stroma. Intimal sclerosis and localized proliferative papillary projections in the vena cava cranial to areas of myointimal hyperplasia occurred infrequently. Traumatic lesions, regardless of location or severity, did not extend below the internal elastic membrane. Inflammatory cellular responses, when present, were minimal. The location, distribution, and morphogenesis of catheter-related cardiovascular lesions distinguishes them from those induced by chemical toxicity or pharmacotoxicity.
Asunto(s)
Enfermedades Cardiovasculares/veterinaria , Cateterismo Periférico/veterinaria , Enfermedades de los Perros/etiología , Endocardio/patología , Venas Cavas/patología , Animales , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/patología , Cateterismo Periférico/efectos adversos , Catéteres de Permanencia/efectos adversos , Catéteres de Permanencia/veterinaria , Enfermedades de los Perros/patología , Perros , Femenino , Atrios Cardíacos/patología , Venas Yugulares , Masculino , Microscopía Electrónica , Microscopía Electrónica de Rastreo , Venas Cavas/ultraestructuraRESUMEN
Losulazine was administered orally to 21 bred Sprague-Dawley rats per group at 0, 4, and 8 mg/kg/day by three dosing schedules: gestation day 15 until term (prenatal section); postnatal days 1 to 21 (postnatal section); and gestation day 15 until postnatal day 21 (pre- and postnatal section). Dams were allowed to deliver and the number of live and dead pups recorded. Each pup was sexed and weighed on days 0, 4, and 21. Also, pinna detachment and eye opening were monitored. Randomly selected offspring were allowed to mature and then cohabited for assessment of reproductive performance. Dam body weight gain during dosing was reduced in the high dose group of the pre- and postnatal section. Treated dams in the postnatal and pre- and postnatal sections had litters with reduced body weight, delayed development, and decreased survival. In the F1 mating portion of the postnatal and pre- and postnatal sections, F1 offspring from losulazine-treated dams had reduced body weights over the entire study. A dose-related decrease was found for both the percentage of F1 males that bred and the conception rate of bred F1 females. All F1 females entered estrus at least once, and those that conceived delivered normal litters. Neither microscopic examination of F1 male reproductive organs nor analyses of serum prolactin, luteinizing hormone (LH), and testosterone levels indicated the cause of impaired fertility. Thus, although prenatal exposure only did not result in adverse effects, postnatal exposure to losulazine via lactation affected offspring growth, development, and reproductive capacity.
Asunto(s)
Piperazinas/toxicidad , Efectos Tardíos de la Exposición Prenatal , Administración Oral , Animales , Animales Recién Nacidos/crecimiento & desarrollo , Relación Dosis-Respuesta a Droga , Femenino , Hormonas/sangre , Tamaño de la Camada , Masculino , Piperazinas/administración & dosificación , Embarazo , Ratas , Ratas EndogámicasRESUMEN
Losulazine, a hypotensive agent, was given orally by gastric intubation to Sprague-Dawley rats in doses of 0, 2, 4, or 8 mg/kg/day in a study of fertility and general reproductive performance. Eighteen males per group were treated for 67 days before cohabitation, then daily until killed. Thirty-six females per group were treated for only 14 days because estrous cycles had been disrupted. Females remained untreated for 7 days before cohabitation; treatment was resumed after insemination was confirmed or when the cohabitation period ended. Males were cohabited on a 1:2 basis with females from the same treatment group for up to 14 days, then for 14 days with untreated females. The conception rate of both treated and untreated females was statistically significantly decreased as the dose increased. Mean body weights were statistically significantly greater and mean gestation periods were statistically significantly longer in losulazine-treated females than in females of the vehicle control group. Throughout the preweaning period mean body weights were significantly less in offspring from treated dams than in offspring of dams in the vehicle control group. This adverse effect on weight gain continued in male offspring until at least postpartum day 79. Functional development was significantly delayed in the offspring of losulazine-treated dams tested for pinna detachment, auditory startle, negative geotaxis, eye opening, and learning (swimming M-maze). Delays in development were generally greater in offspring of dams and sires treated with higher doses of losulazine. Fertility of male offspring from dams and sires treated with losulazine at 4 and 8 mg/kg/day was also affected adversely.
Asunto(s)
Antihipertensivos/toxicidad , Crecimiento/efectos de los fármacos , Piperazinas/toxicidad , Reproducción/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Blefaroptosis/inducido químicamente , Relación Dosis-Respuesta a Droga , Estro/efectos de los fármacos , Femenino , Masculino , Embarazo , Ratas , Ratas Endogámicas , Testículo/efectos de los fármacos , Testículo/patologíaRESUMEN
Groups of 5 male beagle dogs were treated orally with hydralazine tablets in gelatin capsules at a dose of 12 or 24 mg/kg twice a day (6 hours apart) for 2 consecutive days. Five male dogs treated with empty gelatin capsules served as untreated controls. Clinical findings and heart rate changes during treatment and terminal body weight, hematology, and blood chemistry changes were evaluated. The heart, liver, kidneys, spleen, and thymus of each animal were examined microscopically. Dogs in the 12 mg/kg group ate less than control group. Dogs treated with 24 mg/kg did not eat and vomited. Heart rates in both of the treated groups increased by 60% to 80% within 2 hours of treatment and remained high during the entire treatment period. Significant hematologic change was confined to a slight increase in platelet number of dogs treated with 24 mg/kg. Serum glucose was increased in the hydralazine treated dogs. Conjugated serum bilirubin was increased and serum potassium, chloride and phosphorus were decreased in the 24 mg/kg group. Blood urea nitrogen and serum chloride were slightly increased in dogs treated with 12 mg/kg. Treatment-related pathologic alterations were confined to the heart. Two dogs from each of the hydralazine groups experienced acute localized hemorrhage into the epicardium and subepicardium of the right atrium. The media of the muscular branches of the coronary arteries, especially the left coronary artery, was hemorrhagic in 3 dogs from the 24 mg/kg group. Medial necrosis, when seen, tended to be proportional to the severity of medial hemorrhages. There was no necrosis in the papillary muscles of the heart.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Corazón/efectos de los fármacos , Hidralazina/toxicidad , Animales , Análisis Químico de la Sangre , Peso Corporal/efectos de los fármacos , Perros , Frecuencia Cardíaca/efectos de los fármacos , Hemorragia/inducido químicamente , Masculino , Miocardio/patología , NecrosisRESUMEN
The mechanism of anestrus in rats treated with losulazine, a peripheral sympatholytic antihypertensive agent, was investigated by determining its effect on hypothalamic catecholamines and serum sex hormones and by evaluating the influence of bromocriptine on the reproductive functions of rats treated with losulazine. Groups of six female Upjohn Sprague-Dawley rats were treated orally with 10 mg/kg/day of losulazine and/or 18.75 mg/kg/day of bromocriptine for 15 or 27 days. Six rats were treated with losulazine plus 6.25 mg/kg/day of bromocriptine for 16 days followed by losulazine alone for 11 days. Rats treated with losulazine only were depleted of hypothalamic catecholamines, were hyperprolactinemic, and had interrupted estrous cycles and attenuated vaginal mucosa. Treatment with bromocriptine, a dopamine receptor agonist, resulted in suppression of serum prolactin and normal estrous cycles. Rats reverted back to hyperprolactinemia and anestrus shortly after bromocriptine withdrawal. These results suggest that hyperprolactinemia mediated through hypothalamic dopamine depletion is the mechanism of anestrus in rats treated with losulazine.
Asunto(s)
Anestro/efectos de los fármacos , Antihipertensivos/farmacología , Estro/efectos de los fármacos , Piperazinas/farmacología , Anestro/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Bromocriptina/farmacología , Catecolaminas/sangre , Dopamina/metabolismo , Femenino , Hormona Folículo Estimulante/sangre , Genitales Femeninos/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Progesterona/sangre , Prolactina/sangre , Ratas , Ratas EndogámicasRESUMEN
Pseudorabies virus (PRV) was not transmitted horizontally from 3 PRV-infected calves to 2 contact control calves during 4 days of comingling in experiment 1. Although these contact control calves developed clinical signs of pseudorabies when infected intranasally with PRV in experiment 2, they did not transmit PRV to a second pair of contact control calves. However, 1 of 2 pigs comingled with these 4 calves seroconverted. During both experiments, moderate amounts (10(2) to 10(5) TCID50) of PRV were present in the nasal secretions of the infected calves during the contact periods. All infected calves traumatized their nares or periorbital tissue. Infected calves developed a nonsuppurative meningoencephalitis mainly involving the brain stem. Four of the 5 infected calves had nonsuppurative ganglioneuritis and acute lymphoid necrosis of germinal centers. Virus could not be recovered from nasal and tonsillar swab samples from contact-control calves and pigs.
Asunto(s)
Enfermedades de los Bovinos/transmisión , Seudorrabia/transmisión , Animales , Bovinos , Sistema Nervioso Central/microbiología , Sistema Nervioso Central/patología , Conjuntiva/microbiología , Herpesvirus Suido 1/aislamiento & purificación , Masculino , Mucosa Nasal/microbiología , Tonsila Palatina/microbiología , Seudorrabia/patología , Porcinos , Enfermedades de los Porcinos/transmisión , Nervio Trigémino/microbiologíaRESUMEN
A latent pseudorabies virus infection was established in pigs despite vaccination with a modified-live pseudorabies virus vaccine. Although the vaccinated pigs developed high concentrations of antibody, virus was recovered from the tonsils and lungs of pigs treated with dexamethasone three months after inoculation with virulent virus. These results may explain why vaccination programs have failed to eliminate the persistence and spread of virulent pseudorabies virus in infected herds.
Asunto(s)
Seudorrabia/etiología , Enfermedades de los Porcinos/etiología , Porcinos/inmunología , Vacunación/veterinaria , Animales , Dexametasona/farmacología , Femenino , Herpesvirus Suido 1/aislamiento & purificación , Masculino , Tonsila Palatina/microbiología , Seudorrabia/inmunología , Seudorrabia/microbiología , Enfermedades de los Porcinos/inmunología , Enfermedades de los Porcinos/microbiologíaRESUMEN
Solitary plasmacytomas are rare occurrences in dogs, consequently their potential for malignancy is undetermined. A solitary plasmacytoma was removed from the perianal region of a dog. The dog was clinically normal at that time, but was killed one year later as a result of hind limb stiffness and uremia. At the postmortem examination a disseminated myeloma was found, involving the vertebral column, liver, spleen, bone marrow and visceral lymph nodes.